Skip to main content

Advertisement

A federal judge temporarily blocks Trump administration's new NIH funding policy

A laboratory studying sickle cell disease at the National Heart, Lung, and Blood Institute's Cellular and Molecular Therapeutics Laboratory, at the National Institutes of Health on Feb. 8, 2024, in Bethesda, Md. (AFP via Getty Images)
A laboratory studying sickle cell disease at the National Heart, Lung, and Blood Institute's Cellular and Molecular Therapeutics Laboratory, at the National Institutes of Health on Feb. 8, 2024, in Bethesda, Md. (AFP via Getty Images)

This article was originally published on February 08, 2025.

Related:

Advertisement

Advertisement

Listen Live